Preclinical Safety of Baxter's Recombinant Factor VIIa

被引：0
|
作者：
Dietrich, Barbara [1 ]
Kubik, Susan [1 ]
Auer, Wilfried [1 ]
Reipert, Birgit [1 ]
Horling, Frank [1 ]
Ehrlich, Hartmut J. [1 ]
Scheiflinger, Friedrich [1 ]
Schwarz, Hans Peter [1 ]
Muchitsch, Eva Maria [1 ]
机构：
[1] Baxter Innovat GmbH, Vienna, Austria
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [1] Preclinical Immunogenicity Assessment of Baxter's Recombinant Factor VIIa
    Horling, Frank M.
    Lenk, Christine
    Ahmad, Rafi Uddin
    Weiller, Markus
    Schuster, Maria
    Schwarz, Hans Peter
    Reipert, Birgit M.
    [J]. BLOOD, 2011, 118 (21) : 1430 - 1430
  • [2] Preclinical safety pharmacology of Baxter's recombinant factor IX
    Dietrich, B.
    Kubik, S.
    Ehrlich, H.
    Scheiflinger, F.
    Schwarz, H. P.
    Muchitsch, E. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 118 - 118
  • [3] Preclinical safety of a new recombinant factor VIIa
    Dietrich, B.
    Kubic, S.
    Auer, W.
    Reipert, B.
    Horling, F.
    Ehrlich, H.
    Scheiflinger, F.
    Schwarzh, H.
    Muchitsch, E.
    [J]. HAEMOPHILIA, 2012, 18 : 34 - 34
  • [4] Baxter's recombinant factor VIIA: comparative preclinical immunogenicity assessment using novel mouse models
    Horling, F.
    Lenk, C.
    Ahmad, R. U.
    Weiller, M.
    Schuster, M.
    Schwarz, H-P
    Reipert, B. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 683 - 683
  • [5] Assessment of preclinical safety for BAX 326, Baxter's recombinant human factor IX
    Dietrich, B.
    Kubik, S.
    Auer, W.
    Wuersch, K.
    Reipert, B.
    Horling, F.
    Wolfsegger, M.
    Ehrlich, H.
    Scheiflinger, F.
    Schwarz, H.
    Muchitsch, E.
    [J]. HAEMOPHILIA, 2012, 18 : 39 - 39
  • [6] Efficacy of Baxter's recombinant factor VIIA in animal models of hemophilia
    Schiviz, A.
    Lawo, J. P.
    Resch, M.
    Leidenmuehler, P.
    Bischetsrieder, B.
    Ehrlich, H.
    Scheiflinger, F.
    Schwarz, H-P
    Hoellriegl, W.
    Muchitsch, E-M
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 134 - 134
  • [7] Preclinical Safety of Baxter's Recombinant ADAMTS13
    Piskernik, Christina
    Dietrich, Barbara
    Kubik, Susan
    Ruthsatz, Tanja
    Scheiflinger, Friedrich
    Schwarz, Hans Peter
    Muchitsch, Eva-Maria
    [J]. BLOOD, 2012, 120 (21)
  • [8] Preclinical safety of Baxter's recombinant ADAMTS13
    Piskernik, C.
    Dietrich, B.
    Horling, F.
    Kubik, S.
    Ruthsatz, T.
    Scheiflinger, F.
    Schwarz, H. P.
    Muchitsch, E. M.
    Schiviz, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 789 - 790
  • [9] Preclinical trauma studies of recombinant factor VIIa
    Schreiber, MA
    Holcomb, JB
    Rojkjaer, R
    [J]. CRITICAL CARE, 2005, 9 (Suppl 5): : S25 - S28
  • [10] Preclinical trauma studies of recombinant factor VIIa
    Martin A Schreiber
    John B Holcomb
    Rasmus Rojkjaer
    [J]. Critical Care, 9
12345